Iradimed Stock Target Price and Analyst Consensus
| IRMD Stock | USD 52.45 1.01 1.96% |
The current analyst and expert consensus on Iradimed is Strong Buy, with only one strong buy opinion. The current projected Iradimed target price consensus is 65.00 with 2 analyst opinions. Check out Macroaxis Advice on Iradimed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Iradimed analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Iradimed executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Iradimed. We encourage you to use your own analysis of Iradimed to validate this buy or sell advice. Iradimed buy-or-sell recommendation module provides average expert sentiment on the projected Iradimed target price to derive its highest and lowest estimates based on projected price volatility of 1.8625.
Lowest Forecast 59.15 | Highest Forecast 72.15 | Target Price 65 |
Iradimed |
It's important to approach Iradimed's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Iradimed price targets
Iradimed's stock target price is an estimate of its future price, usually made by analysts. Using Iradimed's target price to determine if it is a suitable investment can be done through the following steps:- Look at Iradimed's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Iradimed's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Iradimed Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Iradimed is a key component of Iradimed valuation and have some predictive power on the future returns of a Iradimed.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | ESG Investing Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Business Services Invested few shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Macroaxis Picks Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Basic Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Iradimed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Please note, the presentation of Iradimed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Iradimed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Iradimed's management manipulating its earnings.